Latest ADAR1 Capital Management, LLC Stock Portfolio
ADAR1 Capital Management, LLC Performance:
2024 Q3: 6.44%YTD: 8.55%
Performance for 2024 Q3 is 6.44%, and YTD is 8.55%.
About ADAR1 Capital Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ADAR1 Capital Management, LLC reported an equity portfolio of $614.9 Millions as of 30 Sep, 2024.
The top stock holdings of ADAR1 Capital Management, LLC are CYTK, PTGX, BBIO. The fund has invested 7.8% of it's portfolio in CYTOKINETICS INC and 7.2% of portfolio in PROTAGONIST THERAPEUTICS INC.
The fund managers got completely rid off UNIQURE NV (QURE), CEREVEL THERAPEUTICS HLDNG I (CERE) and ACASTI PHARMA INC (ACST) stocks. They significantly reduced their stock positions in ACHIEVE LIFE SCIENCES INC (ACHV), MERCK & CO INC (MRK) and APPLIED THERAPEUTICS INC (APLT). ADAR1 Capital Management, LLC opened new stock positions in ZURA BIO LTD, XENCOR INC (XNCR) and SYNDAX PHARMACEUTICALS INC (SNDX). The fund showed a lot of confidence in some stocks as they added substantially to REGENXBIO INC (RGNX), MASIMO CORP (MASI) and LEXEO THERAPEUTICS INC.
The top stock holdings of ADAR1 Capital Management, LLC are CYTK, PTGX, BBIO. The fund has invested 7.8% of it's portfolio in CYTOKINETICS INC and 7.2% of portfolio in PROTAGONIST THERAPEUTICS INC.
The fund managers got completely rid off UNIQURE NV (QURE), CEREVEL THERAPEUTICS HLDNG I (CERE) and ACASTI PHARMA INC (ACST) stocks. They significantly reduced their stock positions in ACHIEVE LIFE SCIENCES INC (ACHV), MERCK & CO INC (MRK) and APPLIED THERAPEUTICS INC (APLT). ADAR1 Capital Management, LLC opened new stock positions in ZURA BIO LTD, XENCOR INC (XNCR) and SYNDAX PHARMACEUTICALS INC (SNDX). The fund showed a lot of confidence in some stocks as they added substantially to REGENXBIO INC (RGNX), MASIMO CORP (MASI) and LEXEO THERAPEUTICS INC.
ADAR1 Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that ADAR1 Capital Management, LLC made a return of 6.44% in the last quarter. In trailing 12 months, it's portfolio return was 31.2%.
New Buys
| Ticker | $ Bought |
|---|---|
| zura bio ltd | 15,308,800 |
| aa mission acquisition corp | 10,122,200 |
| xencor inc | 6,882,890 |
| syndax pharmaceuticals inc | 6,741,470 |
| biogen inc | 5,742,510 |
| dianthus therapeutics inc | 3,251,050 |
| acasti pharma inc | 2,878,710 |
| pieris pharmaceuticals inc | 2,398,150 |
New stocks bought by ADAR1 Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| regenxbio inc | 20,974 |
| masimo corp | 10,147 |
| lexeo therapeutics inc | 4,297 |
| rocket pharmaceuticals inc | 4,200 |
| arcellx inc | 3,862 |
| mineralys therapeutics inc | 2,775 |
| exact sciences corp | 2,433 |
| pliant therapeutics inc | 2,361 |
Additions to existing portfolio by ADAR1 Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| achieve life sciences inc | -99.98 |
| merck & co inc | -98.5 |
| applied therapeutics inc | -97.28 |
| mitek sys inc | -96.43 |
| edgewise therapeutics inc | -95.84 |
| intelligent bio solutions in | -95.02 |
| equillium inc | -94.8 |
| viking therapeutics inc | -92.22 |
ADAR1 Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| uniqure nv | -5,477,590 |
| acasti pharma inc | -2,801,950 |
| vaxart inc | -630,978 |
| angiodynamics inc | -870,365 |
| kezar life sciences inc | -651,899 |
| movano inc | -386,925 |
| cerevel therapeutics hldng i | -3,817,080 |
| elevation oncology inc | -229,303 |
ADAR1 Capital Management, LLC got rid off the above stocks
Sector Distribution
ADAR1 Capital Management, LLC has about 70.6% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 70.6 |
| Others | 28.4 |
Market Cap. Distribution
ADAR1 Capital Management, LLC has about 9.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 39.7 |
| UNALLOCATED | 28.4 |
| SMALL-CAP | 16.7 |
| LARGE-CAP | 9.7 |
| MICRO-CAP | 3.6 |
| NANO-CAP | 1.7 |
Stocks belong to which Index?
About 48.1% of the stocks held by ADAR1 Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 51.9 |
| RUSSELL 2000 | 46.4 |
| S&P 500 | 1.7 |
ADAR1 Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC has 258 stocks in it's portfolio. About 53.3% of the portfolio is in top 10 stocks. ITOS proved to be the most loss making stock for the portfolio. PTGX was the most profitable stock for ADAR1 Capital Management, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AAXJ | ishares tr | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABCL | abcellera biologics inc | 0.05 | 114,981 | 298,951 | new | |||
| ABEO | abeona therapeutics inc | 0.03 | 24,322 | 153,715 | reduced | -78.5 | ||
| ABIO | arca biopharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABSI | absci corporation | 0.62 | 1,005,750 | 3,841,960 | reduced | -40.79 | ||
| ABT | abbott labs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABUS | arbutus biopharma corp | 1.31 | 2,089,320 | 8,043,890 | reduced | -36.48 | ||
| ACAD | acadia pharmaceuticals inc | 0.06 | 23,100 | 355,278 | added | 1,676 | ||
| ACHV | achieve life sciences inc | 0.00 | 91.00 | 431 | reduced | -99.98 | ||
| ACLX | arcellx inc | 0.05 | 3,962 | 330,867 | added | 3,862 | ||
| ACRS | aclaris therapeutics inc | 0.02 | 90,000 | 103,500 | new | |||
| ACST | acasti pharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ADVM | adverum biotechnologies inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ADXN | addex therapeutics ltd | 0.00 | 1,000 | 9,770 | added | 11.11 | ||
| AGIO | agios pharmaceuticals inc | 0.15 | 21,300 | 946,359 | new | |||
| AGLE | spyre therapeutics inc | 0.06 | 12,560 | 369,390 | reduced | -64.3 | ||
| AGR | avangrid inc | 0.13 | 23,000 | 823,170 | unchanged | 0.00 | ||
| AIMAU | aimfinity investment corp i | 0.00 | 18,000 | 362 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 0.11 | 23,007 | 660,071 | reduced | -9.8 | ||
| ALCC | oklo inc | 0.00 | 1,000 | 8,090 | unchanged | 0.00 | ||